Comparison of the Efficacy of Inhaled Versus Infused Milrinone in the Management of Persistent Pulmonary Hypertension in Infants in Resource-Limited Settings A Randomized Clinical Trial
Abstract:Background: Standard treatment of persistent pulmonary hypertension in neonates (PPHN) is inhaled nitric oxide (iNO), which is not available in Iran. Consequently, other drugs such as milrinone are prescribed. So far, no study has investigated the effect of inhaled milrinone on the management of PPHN.Our study was designed for better management of PPHN in the absence of iNO.Methods: In this randomized clinical trial, neonates with PPHN admitted Neonatal intensive care unit of Hazrat Ali Asghar and Akbarabadi h… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.